December 4, 2019 Off

Anavex Life Sciences Presents ANAVEX trials on Alzheimer’s-

By Dino Mustafić

Anavex Life Scienceshas announced late breaking oral communication at CTAD 2019, by presenting the interim 2-Year (104)-Week) data from the Phase 2a ANAVEX®2-73 (blarcamesine) extension study, with Alzheimer’s disease patients followed for up to five years, at the 12th Clinical Trials On Alzheimer’s Disease (CTAD) 2019 Conference in San Diego, CA (December 4-7, 2019).

December 4, 2019 Off

Bayer tranforming IT function to digitalize

By Dino Mustafić

Bayer said Wednesday it is transforming its IT function to further accelerate the digitalization of the company, by which leading IT providers will take over standardized services, such as the provision of digital workplaces for employees or the global operation of IT infrastructure.